Laquinimod, a Quinoline-3-Carboxamide, Induces Type II Myeloid Cells That Modulate Central Nervous System Autoimmunity

• Ulf Schulze-Topphoff ,

  Contributed equally to this work with: Ulf Schulze-Topphoff, Aparna Shetty

  Affiliation Department of Neurology and Program in Immunology, University of California, San Francisco, San Francisco, California, United States of America

  ⨯
• Aparna Shetty ,

  Contributed equally to this work with: Ulf Schulze-Topphoff, Aparna Shetty

  Affiliation Department of Neurology and Program in Immunology, University of California, San Francisco, San Francisco, California, United States of America

  ⨯
• Michel Varrin-Doyer,

  Affiliation Department of Neurology and Program in Immunology, University of California, San Francisco, San Francisco, California, United States of America

  ⨯
• Nicolas Molnarfi,

  Current address: Department of Pathology and Immunology, University of Geneva, Geneva, Switzerland

  Affiliation Department of Neurology and Program in Immunology, University of California, San Francisco, San Francisco, California, United States of America

  ⨯
• Sharon A. Sagan,

  Affiliation Department of Neurology and Program in Immunology, University of California, San Francisco, San Francisco, California, United States of America

  ⨯
• Raymond A. Sobel,

  Affiliation Department of Pathology, Stanford University, Stanford, California, United States of America

  ⨯
• Patricia A. Nelson,

  Affiliation Department of Neurology and Program in Immunology, University of California, San Francisco, San Francisco, California, United States of America

  ⨯
• Scott S. Zamvil

  * E-mail: zamvil@ucsf.neuroimmunol.org

  Affiliation Department of Neurology and Program in Immunology, University of California, San Francisco, San Francisco, California, United States of America

  ⨯